Synthesis and structure-activity relationship of coumarins as potent Mcl-1 inhibitors for cancer treatment
作者:Yang-Liu Xia、Jing-Jing Wang、Shi-Yang Li、Yong Liu、Frank J. Gonzalez、Ping Wang、Guang-Bo Ge
DOI:10.1016/j.bmc.2020.115851
日期:2021.1
Myeloid cell leukemia-1 (Mcl-1) is a validated and attractive target for cancer therapy. Over-expression of Mcl-1 in many cancers allows cancer cells to evade apoptosis and contributes to their resistance to current chemotherapeutics. In this study, more than thirty coumarin derivatives with different substituents were designed and synthesized, and their Mcl-1 inhibitory activities evaluated using
髓样细胞白血病-1 (Mcl-1) 是经过验证且有吸引力的癌症治疗靶点。 Mcl-1 在许多癌症中的过度表达使癌细胞能够逃避细胞凋亡,并有助于它们对当前化疗药物的抵抗。在本研究中,设计并合成了三十多种具有不同取代基的香豆素衍生物,并使用基于荧光偏振的结合测定评估了它们的 Mcl-1 抑制活性。结果表明,儿茶酚基团是香豆素类Mcl-1抑制活性的关键组成部分,儿茶酚基团的甲基化导致抑制活性降低。在6,7-二羟基香豆素的C-4位引入疏水性吸电子基团,增强了Mcl-1抑制能力,而在该位置引入亲水基团则不利于抑制效力。此外,在C-5或C-8位引入含氮基团,允许形成分子内氢键,也不利于Mcl-1抑制。在所有测试的香豆素中,4-三氟甲基-6,7-二羟基香豆素 (Cpd 4 ) 对 Mcl-1 显示出最有效的抑制活性(分别为K i = 0.21 ± 0.02 μM, IC 50 = 1.21 ± 0.56